- Home
- JBI vs XNCR Comparison
JBI vs XNCR Comparison
Compare JBI & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBI
- XNCR
- Stock Information
- Founded
- JBI 2002
- XNCR 1997
- Country
- JBI United States
- XNCR United States
- Employees
- JBI N/A
- XNCR N/A
- Industry
- JBI Building Products
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- JBI Industrials
- XNCR Health Care
- Exchange
- JBI Nasdaq
- XNCR Nasdaq
- Market Cap
- JBI 1.5B
- XNCR 1.7B
- IPO Year
- JBI N/A
- XNCR 2013
- Fundamental
- Price
- JBI $7.66
- XNCR $24.20
- Analyst Decision
- JBI Buy
- XNCR Strong Buy
- Analyst Count
- JBI 5
- XNCR 9
- Target Price
- JBI $10.25
- XNCR $36.33
- AVG Volume (30 Days)
- JBI 1.6M
- XNCR 850.2K
- Earning Date
- JBI 10-29-2024
- XNCR 11-06-2024
- Dividend Yield
- JBI N/A
- XNCR N/A
- EPS Growth
- JBI N/A
- XNCR N/A
- EPS
- JBI 0.72
- XNCR N/A
- Revenue
- JBI $996,800,000.00
- XNCR $85,164,000.00
- Revenue This Year
- JBI N/A
- XNCR N/A
- Revenue Next Year
- JBI N/A
- XNCR $89.22
- P/E Ratio
- JBI $10.59
- XNCR N/A
- Revenue Growth
- JBI N/A
- XNCR N/A
- 52 Week Low
- JBI $6.68
- XNCR $15.31
- 52 Week High
- JBI $15.86
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- JBI 44.97
- XNCR 44.92
- Support Level
- JBI $7.30
- XNCR $22.74
- Resistance Level
- JBI $8.10
- XNCR $25.54
- Average True Range (ATR)
- JBI 0.29
- XNCR 1.17
- MACD
- JBI 0.04
- XNCR -0.33
- Stochastic Oscillator
- JBI 28.12
- XNCR 22.00
About JBI Janus International Group Inc.
Janus International Group Inc is a manufacturer and supplier of turnkey solutions for self-storage, commercial, and industrial building Solutions. The company provides products that include roll-up and swing doors, hallway systems, relocatable storage MASS (Moveable Additional Storage Structures) units, and technologies for automating facility and door operation. It is operated through two geographic regions; Janus North America and Janus International. . The Janus International segment is comprised of Janus International Europe Holdings Ltd whose production and sales are largely in Europe and Australia. The Janus North America segment is comprised of all the other entities including Janus Core together with each of its operating subsidiaries, Betco, Inc.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.